Results 91 to 100 of about 14,279 (236)
Classifying pro-fibrations and shape fibrations
We first describe some categories. Let TOP denote the category whose objects are topological spaces and whose morphisms are continuous maps. Let \(TOP^ N\) denote the category whose objects are the inverse systems in TOP indexed by the set of natural numbers \({\mathbb{N}}\) (with continuous bonding maps).
Hastings, Harold M., Waner, Stefan
openaire +2 more sources
IDO‐1 immunostaining identifies primary biliary cholangitis even in morphologically subtle bile duct lesions. IDO‐1 expression reflects cholangitis activity and is suppressed by ursodeoxycholic acid treatment, indicating its value as a dynamic diagnostic adjunct rather than a static marker of chronic damage.
Kaori Yoshimura +10 more
wiley +1 more source
Fenofibrate treatment increases human serum proprotein convertase subtilisin kexin type 9 levels
Over the past several years, proprotein convertase subtilisin kexin type 9 (PCSK9) has gained significant attention as a key regulator of serum LDL-cholesterol (LDL-C) levels.
Jason S. Troutt +3 more
doaj +1 more source
Fibred fibration categories [PDF]
We introduce fibred type-theoretic fibration categories which are fibred categories between categorical models of Martin-Löf type theory. Fibred type-theoretic fibration categories give a categorical description of logical predicates for identity types. As an application, we show a relational parametricity result for homotopy type theory.
openaire +2 more sources
Immune Consequences of Metabolic Syndrome and Its Treatment: A Cytokine Perspective
Peripheral blood mononuclear cells (PBMCs) from individuals with metabolic syndrome (MetS) who were not using glucose‐and/or lipid lowering medication (GLLM) exhibited a broader cytokine production profile after in vitro antigen‐specific stimulation than PBMCs from individuals with MetS using such medications and from healthy donors.
Isabela Ghetti Macedo Isaac +7 more
wiley +1 more source
Mechanism of action of fibrates on lipid and lipoprotein metabolism
Treatment with fibrates, a widely used class of lipid-modifying agents, results in a substantial decrease in plasma triglycerides and is usually associated with a moderate decrease in LDL cholesterol and an increase in HDL cholesterol concentrations ...
Staels, B. +5 more
core +1 more source
Fibrates and coronary risk reduction
Many medications are currently available to correct lipoprotein abnormalities when lifestyle measures alone are not sufficient. No single agent or class of agents is able to correct all of the lipoprotein abnormalities. This paper reviews the role of one
George Steiner
core
This study evaluated serum miRNAs as biomarkers in adult patients with SPIDDM. Serum miRNAs were measured at the time of SPIDDM (probable) diagnosis, and miR‐150‐5p was inversely associated with CPI at the last outpatient visit, suggesting its potential utility for predicting subsequent insulin secretory decline.
Hideyuki Okuma +4 more
wiley +1 more source
This analysis evaluates the effects on lipoprotein subfractions and LDL particle size of ezetimibe/simvastatin with or without coadministration of fenofibrate in patients with mixed hyperlipidemia.
Michel Farnier +4 more
doaj +1 more source
This prespecified subgroup analysis of the BIRDIE study demonstrated that Bifidobacterium bifidum G9‐1 improved stool consistency, bowel movement, and quality of life in patients with type 2 diabetes mellitus, chronic kidney disease, and specifically in age ≥ 65 years, male, and those with eGFR ≥60 mL/min/1.73 m2.
Fuki Ikeda +8 more
wiley +1 more source

